Literature DB >> 12782680

The alpha(1A/C)- and alpha(1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse.

Timothy D O'Connell1, Shinji Ishizaka, Akihiro Nakamura, Philip M Swigart, M C Rodrigo, Gregory L Simpson, Susanna Cotecchia, D Gregg Rokosh, William Grossman, Elyse Foster, Paul C Simpson.   

Abstract

Catecholamines and alpha(1)-adrenergic receptors (alpha(1)-ARs) cause cardiac hypertrophy in cultured myocytes and transgenic mice, but heart size is normal in single KOs of the main alpha(1)-AR subtypes, alpha(1A/C) and alpha(1B). Here we tested whether alpha(1)-ARs are required for developmental cardiac hypertrophy by generating alpha(1A/C) and alpha(1B) double KO (ABKO) mice, which had no cardiac alpha(1)-AR binding. In male ABKO mice, heart growth after weaning was 40% less than in WT, and the smaller heart was due to smaller myocytes. Body and other organ weights were unchanged, indicating a specific effect on the heart. Blood pressure in ABKO mice was the same as in WT, showing that the smaller heart was not due to decreased load. Contractile function was normal by echocardiography in awake mice, but the smaller heart and a slower heart rate reduced cardiac output. alpha(1)-AR stimulation did not activate extracellular signal-regulated kinase (Erk) and downstream kinases in ABKO myocytes, and basal Erk activity was lower in the intact ABKO heart. In female ABKO mice, heart size was normal, even after ovariectomy. Male ABKO mice had reduced exercise capacity and increased mortality with pressure overload. Thus, alpha(1)-ARs in male mice are required for the physiological hypertrophy of normal postnatal cardiac development and for an adaptive response to cardiac stress.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12782680      PMCID: PMC156101          DOI: 10.1172/JCI16100

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Hypotension, autonomic failure, and cardiac hypertrophy in transgenic mice overexpressing the alpha 1B-adrenergic receptor.

Authors:  M J Zuscik; D Chalothorn; D Hellard; C Deighan; A McGee; C J Daly; D J Waugh; S A Ross; R J Gaivin; A J Morehead; J D Thomas; E F Plow; J C McGrath; M T Piascik; D M Perez
Journal:  J Biol Chem       Date:  2001-02-01       Impact factor: 5.157

2.  The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction.

Authors:  Akito Tanoue; Yoshihisa Nasa; Takaaki Koshimizu; Hitomi Shinoura; Sayuri Oshikawa; Takayuki Kawai; Sachie Sunada; Satoshi Takeo; Gozoh Tsujimoto
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Akt/protein kinase B promotes organ growth in transgenic mice.

Authors:  Tetsuo Shioi; Julie R McMullen; Peter M Kang; Pamela S Douglas; Toshiyuki Obata; Thomas F Franke; Lewis C Cantley; Seigo Izumo
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  Gender differences in autonomic cardiovascular regulation: spectral, hormonal, and hemodynamic indexes.

Authors:  J M Evans; M G Ziegler; A R Patwardhan; J B Ott; C S Kim; F M Leonelli; C F Knapp
Journal:  J Appl Physiol (1985)       Date:  2001-12

5.  Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy.

Authors:  A Rapacciuolo; G Esposito; K Caron; L Mao; S A Thomas; H A Rockman
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

6.  Targeted alpha(1A)-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy.

Authors:  F Lin; W A Owens; S Chen; M E Stevens; S Kesteven; J F Arthur; E A Woodcock; M P Feneley; R M Graham
Journal:  Circ Res       Date:  2001-08-17       Impact factor: 17.367

7.  LV systolic performance improves with development of hypertrophy after transverse aortic constriction in mice.

Authors:  A Nakamura; D G Rokosh; M Paccanaro; R R Yee; P C Simpson; W Grossman; E Foster
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-09       Impact factor: 4.733

8.  Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression.

Authors:  Darrell D Belke; Sandrine Betuing; Martin J Tuttle; Christophe Graveleau; Martin E Young; Mark Pham; Dongfang Zhang; Robert C Cooksey; Donald A McClain; Sheldon E Litwin; Heinrich Taegtmeyer; David Severson; C Ronald Kahn; E Dale Abel
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

9.  Alpha(1)-adrenoceptor subtypes mediate negative inotropy in myocardium from alpha(1A/C)-knockout and wild type mice.

Authors:  Diana T McCloskey; D Gregg Rokosh; Timothy D O'Connell; Edmund C Keung; Paul C Simpson; Anthony J Baker
Journal:  J Mol Cell Cardiol       Date:  2002-08       Impact factor: 5.000

10.  Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure.

Authors:  D Gregg Rokosh; Paul C Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

View more
  73 in total

Review 1.  Sex is a potent modifier of the cardiovascular system.

Authors:  Leslie A Leinwand
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

2.  Alpha1-adrenoceptor subtype substitution in knockout mice.

Authors:  J Paul Hieble
Journal:  Br J Pharmacol       Date:  2004-06-21       Impact factor: 8.739

3.  Nuclear localization drives α1-adrenergic receptor oligomerization and signaling in cardiac myocytes.

Authors:  Casey D Wright; Steven C Wu; Erika F Dahl; Alan J Sazama; Timothy D O'Connell
Journal:  Cell Signal       Date:  2011-11-18       Impact factor: 4.315

4.  Cardiac 7-transmembrane-spanning domain receptor portfolios: diversify, diversify, diversify.

Authors:  Stephen B Liggett
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

5.  Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts.

Authors:  Jinghai Chen; Gregory C Shearer; Quanhai Chen; Chastity L Healy; April J Beyer; Vijaya B Nareddy; A Martin Gerdes; William S Harris; Timothy D O'Connell; Dajun Wang
Journal:  Circulation       Date:  2011-01-31       Impact factor: 29.690

6.  Alpha1-adrenoceptors are required for normal male sexual function.

Authors:  A Sanbe; Y Tanaka; Y Fujiwara; H Tsumura; J Yamauchi; S Cotecchia; K Koike; G Tsujimoto; A Tanoue
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

7.  Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload.

Authors:  Timothy D O'Connell; Philip M Swigart; M C Rodrigo; Shinji Ishizaka; Shuji Joho; Lynne Turnbull; Laurence H Tecott; Anthony J Baker; Elyse Foster; William Grossman; Paul C Simpson
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

8.  A-kinase-anchoring protein-Lbc anchors IκB kinase β to support interleukin-6-mediated cardiomyocyte hypertrophy.

Authors:  Cosmo Damiano del Vescovo; Susanna Cotecchia; Dario Diviani
Journal:  Mol Cell Biol       Date:  2012-10-22       Impact factor: 4.272

Review 9.  G-Protein-Coupled Receptors in Heart Disease.

Authors:  Jialu Wang; Clarice Gareri; Howard A Rockman
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

10.  Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific.

Authors:  Brian C Jensen; Philip M Swigart; Paul C Simpson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-11-07       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.